Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larissa Mooney

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Drug and Alcohol Review|May 7, 2011
Prescription opioid abuse, pain and addiction: clinical issues and implicationsWalter Ling, Larissa Mooney, Maureen Hillhouse
The Psychiatric Clinics of North America|May 30, 2012
Advances in opioid antagonist treatment for opioid addictionWalter Ling, Larissa Mooney, Li-Tzy Wu
Annual Review of Public Health|January 15, 2010
The methamphetamine problem in the United StatesRachel Gonzales, Larissa Mooney, Richard A Rawson
Journal of Substance Abuse Treatment|July 29, 2014
Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination usersSuzanne Nielsen, Maureen Hillhouse, Larissa Mooney, et al.
Journal of Substance Abuse Treatment|January 4, 2011
Prescription and over-the-counter drug treatment admissions to the California public treatment systemRachel Gonzales, Mary-Lynn Brecht, Larissa Mooney, et al.
Journal of Substance Abuse Treatment|February 4, 2012
Comparing buprenorphine induction experience with heroin and prescription opioid usersSuzanne Nielsen, Maureen Hillhouse, Larissa Mooney, et al.
Substance Abuse and Rehabilitation|January 30, 2014
Selective review and commentary on emerging pharmacotherapies for opioid addictionWalter Ling, Larissa Mooney, Min Zhao, et al.
Journal of Addiction Medicine|February 7, 2019
Medication Adherence Monitoring Using Smartphone Video Dosing in an Open-label Pilot Study of Monthly Naltrexone Plus Once-daily Bupropion for Methamphetamine Use Disorder: Feasibility and AcceptabilityRobrina Walker, Maureen Hillhouse, Brian Perrochet, et al.
Advances in Drug and Alcohol Research|March 10, 2022
Mechanisms Underlying the Anti-Suicidal Treatment Potential of BuprenorphineCourtney M Cameron, Steven Nieto, Lucienne Bosler, et al.
Journal of Substance Abuse Treatment|July 22, 2008
Hepatitis A and B infection among methamphetamine-dependent usersRachel Gonzales, Patricia Marinelli-Casey, Maureen Hillhouse, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Drug and Alcohol Review|May 7, 2011
Prescription opioid abuse, pain and addiction: clinical issues and implicationsWalter Ling, Larissa Mooney, Maureen Hillhouse
The Psychiatric Clinics of North America|May 30, 2012
Advances in opioid antagonist treatment for opioid addictionWalter Ling, Larissa Mooney, Li-Tzy Wu
Annual Review of Public Health|January 15, 2010
The methamphetamine problem in the United StatesRachel Gonzales, Larissa Mooney, Richard A Rawson
Journal of Substance Abuse Treatment|July 29, 2014
Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination usersSuzanne Nielsen, Maureen Hillhouse, Larissa Mooney, et al.
Journal of Substance Abuse Treatment|January 4, 2011
Prescription and over-the-counter drug treatment admissions to the California public treatment systemRachel Gonzales, Mary-Lynn Brecht, Larissa Mooney, et al.
Journal of Substance Abuse Treatment|February 4, 2012
Comparing buprenorphine induction experience with heroin and prescription opioid usersSuzanne Nielsen, Maureen Hillhouse, Larissa Mooney, et al.
Substance Abuse and Rehabilitation|January 30, 2014
Selective review and commentary on emerging pharmacotherapies for opioid addictionWalter Ling, Larissa Mooney, Min Zhao, et al.
Journal of Addiction Medicine|February 7, 2019
Medication Adherence Monitoring Using Smartphone Video Dosing in an Open-label Pilot Study of Monthly Naltrexone Plus Once-daily Bupropion for Methamphetamine Use Disorder: Feasibility and AcceptabilityRobrina Walker, Maureen Hillhouse, Brian Perrochet, et al.
Advances in Drug and Alcohol Research|March 10, 2022
Mechanisms Underlying the Anti-Suicidal Treatment Potential of BuprenorphineCourtney M Cameron, Steven Nieto, Lucienne Bosler, et al.
Journal of Substance Abuse Treatment|July 22, 2008
Hepatitis A and B infection among methamphetamine-dependent usersRachel Gonzales, Patricia Marinelli-Casey, Maureen Hillhouse, et al.
Pageof 3